» Articles » PMID: 10332669

Risk for Metabolic Control Problems in Minority Youth with Diabetes

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 1999 May 20
PMID 10332669
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We examined and quantified the degree of risk for poor glycemic control and hospitalizations for diabetic ketoacidosis (DKA) among black, Hispanic, and white children and adolescents with diabetes.

Research Design And Methods: We examined ethnic differences in metabolic control among 68 black, 145 Hispanic, and 44 white children and adolescents with type 1 diabetes (mean age 12.9 [range 1-21] years), who were primarily of low socioeconomic status. Clinical and demographic data were obtained by medical chart review. Glycohemoglobins were standardized and compared across ethnic groups. Odds ratios among the ethnic groups for poor glycemic control and hospitalizations for DKA were also calculated.

Results: The ethnic groups were not different with respect to age, BMI, insulin dose, or hospitalizations for DKA, but black children were older at the time of diagnosis than Hispanics (P < 0.05) and were less likely to have private health insurance than white and Hispanic children (P < 0.001). Black youths had higher glycohemoglobin levels than white and Hispanic youths (P < 0.001 after controlling for age at diagnosis). Black youths were also at greatest risk for poor glycemic control (OR = 3.9, relative to whites; OR = 2.5, relative to Hispanics).

Conclusions: These results underscore and quantify the increased risk for glycemic control problems of lower-income, black children with diabetes. In the absence of effective intervention, these youths are likely to be overrepresented in the health care system as a result of increased health complications related to diabetes.

Citing Articles

Metabolic control of diabetic patients assisted by private and public health care systems during the COVID-19 pandemic: A retrospective cohort study.

Alves A, Canaan M, Baruqui Junior A, Barros F, Andrade E, Castelo P Prim Care Diabetes. 2023; 17(3):242-249.

PMID: 37031080 PMC: 10070783. DOI: 10.1016/j.pcd.2023.04.001.


Forty Years of Behavioral Diabetes Research: A Personal Journey.

Delamater A Diabetes Spectr. 2023; 36(1):88-96.

PMID: 36818415 PMC: 9935293. DOI: 10.2337/ds22-0086.


Race- and Neighborhood-Related Disparities Spanning the COVID-19 Pandemic: Trajectories of Combined Glycemic Control and BMI in Youth With Diabetes.

Vajravelu M, Mani I, Malik S, Hewitt B, Peyyety V, Arslanian S Diabetes Care. 2022; 46(3):511-518.

PMID: 36534444 PMC: 10020019. DOI: 10.2337/dc22-1439.


Identifying and addressing disparities in the evaluation and treatment of children with growth hormone deficiency.

Beliard K, Wu V, Samuels J, Lipman T, Rapaport R Front Endocrinol (Lausanne). 2022; 13:989404.

PMID: 36093098 PMC: 9448989. DOI: 10.3389/fendo.2022.989404.


Can Innovative Technologies Overcome HbA1c Disparity for African-American Youth with Type 1 Diabetes?.

Chalew S, Delamater A, Washington S, Bhat J, Franz D, Gomez R J Diabetes Sci Technol. 2021; 15(5):1069-1075.

PMID: 34137288 PMC: 8442203. DOI: 10.1177/19322968211021386.